The Taste Modulators Market is expected to reach US$ 1.6 billion by 2023. It is estimated to reach US$ 3.0 billion by 2033, ...

Pharma giant GSK is buying into Rgenta Therapeutics’ mission to develop a pipeline of oral RNA-targeting small molecules. | ...

Dice Alpha Inc. has prepared and tested substituted 6-imidazopyridazine IL-17A modulators potentially useful for the treatment of psoriasis, radiographic axial spondyloarthritis (ankylosing ...

Optical and photonic modulators are technologically advanced devices that enable the manipulation of light properties—such as power and phase—based on input signals. Over the decades ...

Setonix Pharmaceuticals has described peroxisome proliferator-activated receptor γ (PPARγ) modulators reported to be useful for the treatment of inflammatory disorders, metabolic syndrome, obesity, ...

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules ...